Index S&P 500 P/E 26.08 EPS (ttm) 9.21 Insider Own 2.03% Shs Outstand 51.34M Perf Week 3.35%
Market Cap 12.33B Forward P/E 19.30 EPS next Y 12.44 Insider Trans -3.04% Shs Float 50.31M Perf Month -11.90%
Income 474.62M PEG 2.84 EPS next Q 2.06 Inst Own 101.30% Short Float 3.15% Perf Quarter 12.18%
Sales 4.13B P/S 2.99 EPS this Y 3.35% Inst Trans 3.21% Short Ratio 2.97 Perf Half Y 29.51%
Book/sh 70.06 P/B 3.43 EPS next Y 12.83% ROA 6.01% Short Interest 1.58M Perf Year 19.53%
Cash/sh 5.50 P/C 43.64 EPS next 5Y 9.19% ROE 14.44% 52W Range 161.65 - 275.00 Perf YTD 1.58%
Dividend Est. - P/FCF 33.75 EPS past 5Y 14.84% ROI 7.12% 52W High -12.68% Beta 1.43
Dividend TTM - Quick Ratio 1.16 Sales past 5Y 12.89% Gross Margin 33.56% 52W Low 48.55% ATR (14) 7.07
Dividend Ex-Date - Current Ratio 1.52 EPS Y/Y TTM -3.17% Oper. Margin 15.82% RSI (14) 43.90 Volatility 2.90% 2.55%
Employees 21800 Debt/Eq 0.87 Sales Y/Y TTM 3.86% Profit Margin 11.49% Recom 1.94 Target Price 271.56
Option/Short Yes / Yes LT Debt/Eq 0.85 EPS Q/Q -0.65% Payout 0.00% Rel Volume 0.00 Prev Close 240.13
Sales Surprise 2.24% EPS Surprise 2.42% Sales Q/Q -7.85% Earnings May 09 BMO Avg Volume 533.03K Price 240.13
SMA20 -3.41% SMA50 -5.04% SMA200 11.10% Trades
Volume 0 Change 0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-15-24 Downgrade Guggenheim
Buy → Neutral
Sep-13-23 Initiated TD Cowen
Market Perform
$212
Jul-10-23 Downgrade Citigroup
Buy → Neutral
$260 → $225
Feb-23-23 Upgrade Guggenheim
Neutral → Buy
$255
Jan-12-23 Downgrade Jefferies
Buy → Hold
Sep-30-22 Upgrade Jefferies
Hold → Buy
$240
Aug-25-22 Initiated Credit Suisse
Outperform
$285
Aug-04-22 Downgrade Morgan Stanley
Overweight → Equal-Weight
$350 → $250
May-24-22 Initiated Guggenheim
Neutral
Apr-25-22 Downgrade Jefferies
Buy → Hold
$370 → $280
Apr-07-22 Initiated Stephens
Overweight
$377
Feb-17-22 Upgrade Citigroup
Neutral → Buy
$400
Feb-17-22 Reiterated UBS
Buy
$465 → $420
Feb-17-22 Reiterated Morgan Stanley
Overweight
$465 → $430
Feb-17-22 Reiterated Deutsche Bank
Buy
$409 → $350
Feb-17-22 Reiterated BofA Securities
Buy
$445 → $400
Aug-05-21 Resumed Credit Suisse
Neutral
$385
Dec-16-20 Downgrade Citigroup
Buy → Neutral
$270 → $250
Sep-10-20 Upgrade Jefferies
Hold → Buy
$254
Jul-01-20 Upgrade BofA Securities
Neutral → Buy
$192
Show Previous Ratings
Apr-22-24 08:00AM
Apr-18-24 12:09PM
Apr-16-24 11:50AM
08:00AM
Apr-12-24 08:00AM
09:10AM
Loading…
Apr-11-24 09:10AM
08:00AM
Apr-09-24 08:00AM
Apr-04-24 08:00AM
Apr-01-24 08:00AM
Mar-27-24 08:00AM
Mar-26-24 09:39AM
Mar-23-24 09:00AM
(The Wall Street Journal)
Mar-21-24 08:00AM
Mar-15-24 11:30AM
10:30AM
Loading…
10:30AM
Mar-14-24 09:46AM
08:00AM
Mar-12-24 08:00AM
12:11AM
Mar-07-24 12:27PM
Mar-01-24 11:32PM
Feb-29-24 02:00AM
Feb-26-24 08:41AM
Feb-21-24 10:40AM
08:00AM
Feb-20-24 01:15PM
08:08AM
Feb-15-24 01:00PM
10:54AM
12:38AM
Loading…
12:38AM
Feb-14-24 08:06PM
(Morningstar Research) +11.30%
09:30AM
09:30AM
08:09AM
07:19AM
(Associated Press Finance)
07:00AM
Feb-13-24 08:20AM
Feb-09-24 09:15AM
Feb-01-24 10:08AM
Jan-29-24 08:00AM
Jan-27-24 09:00AM
Jan-24-24 04:30PM
Jan-23-24 04:30PM
Jan-18-24 09:10AM
Jan-16-24 08:00AM
(Investor's Business Daily)
08:00AM
Jan-12-24 02:02PM
09:00AM
Jan-08-24 08:00AM
Jan-02-24 09:00AM
(The Wall Street Journal)
Dec-19-23 08:01AM
Dec-18-23 08:00AM
Dec-13-23 08:29AM
Dec-12-23 08:00AM
Dec-08-23 11:30AM
Dec-07-23 01:53PM
Dec-05-23 07:29AM
Dec-02-23 01:05AM
Nov-29-23 07:57AM
Nov-28-23 08:00AM
Nov-27-23 08:30AM
Nov-22-23 03:04AM
Nov-20-23 08:34PM
Nov-17-23 06:45PM
08:40AM
Nov-16-23 12:59PM
08:00AM
Nov-13-23 09:04AM
Nov-10-23 12:11PM
Nov-09-23 05:14PM
08:00AM
01:33AM
(Thomson Reuters StreetEvents)
Nov-08-23 03:20PM
10:59AM
09:30AM
08:54AM
08:26AM
07:06AM
(Associated Press Finance)
07:00AM
Nov-06-23 10:27AM
Nov-01-23 10:01AM
09:13AM
Oct-25-23 08:06PM
(Morningstar Research) -5.97%
Oct-24-23 12:10PM
Oct-23-23 10:10AM
Oct-19-23 08:00AM
Oct-16-23 08:30AM
08:00AM
Oct-11-23 08:00AM
Oct-10-23 09:10AM
Oct-05-23 12:55PM
Oct-02-23 11:35AM
Sep-27-23 12:04PM
Sep-26-23 08:02AM
08:00AM
Sep-25-23 11:40AM
08:00AM
Sep-21-23 11:36AM
Sep-20-23 08:30AM
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Knell Michael Gunnar CSVP&Chief Accounting Officer Mar 08 '24 Sale 267.52 808 216,156 7,024 Mar 11 04:42 PM Knell Michael Gunnar CSVP&Chief Accounting Officer Mar 04 '24 Sale 261.05 2,750 717,890 7,832 Mar 05 04:54 PM Creamer Victoria L EVP & Chief People Officer Feb 29 '24 Sale 253.70 5,000 1,268,500 13,550 Mar 01 05:37 PM Parisotto Shannon M CEVP, Disc & Safety Assessment Feb 29 '24 Sale 253.45 3,786 959,545 4,792 Mar 04 04:09 PM Barbo William D Corporate Executive VP & CCO Feb 22 '24 Sale 248.50 4,050 1,006,425 22,879 Feb 23 04:57 PM Parisotto Shannon M CEVP, Disc & Safety Assessment Feb 15 '24 Option Exercise 144.67 5,882 850,949 8,478 Feb 20 05:32 PM Parisotto Shannon M CEVP, Disc & Safety Assessment Feb 15 '24 Sale 241.20 5,882 1,418,767 2,596 Feb 20 05:32 PM LaPlume Joseph W EVP, Corp Strategy & Develop Feb 15 '24 Sale 238.93 838 200,223 24,620 Feb 20 05:20 PM FOSTER JAMES C Chairman, President and CEO Jan 29 '24 Option Exercise 144.67 17,436 2,522,466 227,827 Jan 31 04:59 PM Girshick Birgit Corporate Executive VP & COO Jan 10 '24 Option Exercise 215.19 5,916 1,273,064 50,365 Jan 11 04:09 PM Creamer Victoria L EVP & Chief People Officer Dec 14 '23 Option Exercise 136.70 5,526 755,388 22,032 Dec 18 04:07 PM Creamer Victoria L EVP & Chief People Officer Dec 14 '23 Sale 225.00 5,526 1,243,350 16,506 Dec 18 04:07 PM LaPlume Joseph W EVP, Corp Strategy & Develop Nov 30 '23 Sale 197.73 1,850 365,800 23,133 Dec 01 04:10 PM Girshick Birgit Corporate Executive VP & COO Nov 20 '23 Buy 187.82 1,322 248,298 44,449 Nov 21 05:07 PM FOSTER JAMES C Chairman, President and CEO Nov 14 '23 Buy 178.05 5,620 1,000,641 202,643 Nov 15 09:23 AM LaPlume Joseph W EVP, Corp Strategy & Develop Nov 09 '23 Option Exercise 144.67 9,128 1,320,548 34,111 Nov 13 04:12 PM LaPlume Joseph W EVP, Corp Strategy & Develop Nov 09 '23 Sale 173.48 9,128 1,583,522 24,983 Nov 13 04:12 PM WALLMAN RICHARD F Director Aug 24 '23 Buy 198.79 1,000 198,786 1,000 Aug 29 04:23 PM Barbo William D Corporate Executive VP & CCO Aug 10 '23 Option Exercise 144.67 5,511 797,276 9,103 Aug 14 04:17 PM Knell Michael Gunnar CSVP&Chief Accounting Officer Aug 10 '23 Option Exercise 144.67 1,471 212,810 11,411 Aug 14 04:15 PM Barbo William D Corporate Executive VP & CCO Aug 10 '23 Sale 217.24 5,763 1,251,954 3,592 Aug 14 04:17 PM Knell Michael Gunnar CSVP&Chief Accounting Officer Aug 10 '23 Sale 216.54 1,471 318,530 9,940 Aug 14 04:15 PM LaPlume Joseph W EVP, Corp Strategy & Develop Aug 10 '23 Sale 216.52 700 151,564 24,983 Aug 14 04:11 PM LaPlume Joseph W EVP, Corp Strategy & Develop May 15 '23 Sale 190.39 345 65,685 24,026 May 16 02:18 PM LaPlume Joseph W EVP, Corp Strategy & Develop May 12 '23 Sale 193.03 959 185,116 24,371 May 15 02:49 PM MASSARO GEORGE Director May 11 '23 Sale 193.43 288 55,708 4,964 May 15 02:42 PM
Category US Equities - Industry Sector Asset Type Equities (Stocks) Tags U.S. Return% 1Y -3.97% Shs Outstand
Perf Week 0.67%
Sponsor Invesco ETF Type
Tags equity Return% 3Y -6.75% Total Holdings 32 Perf Month -5.75%
Fund Family
Bond Type
Tags biotechnology Return% 5Y 3.48% AUM 231.63M Perf Quarter -6.94%
Index Dynamic Biotechnology & Genome Intellide... Average Maturity
Tags - Return% 10Y
NAV%
Perf Half Y 10.38%
Index Weighting
Commodity Type
Tags - Return% SI
NAV/sh
Perf Year -4.03%
Active/Passive
Quant Type
Tags - Flows% 1M 0.01% 52W Range 52.47 - 67.76 Perf YTD -7.13%
Dividend TTM 0.04 (0.06%) ESG Type
Tags - Flows% 3M -4.69% 52W High -9.76% Beta 0.83
Dividend Ex-Date Mar 18, 2024 Dividend Type
Sector/Theme
Flows% YTD -4.93% 52W Low 16.54% ATR (14) 0.86
Expense 0.58% Structure Type
Region
Flows% 1Y
RSI (14) 40.07 Volatility 1.13% 1.03%
Option/Short Yes / Yes Growth/Value
Dev/Emerg
Flows% 3Y
Rel Volume 0.00 Prev Close 61.15
Inverse/Leveraged
Market Cap
Currency
Flows% 5Y
Avg Volume 15.26K Price 61.15
SMA20 -1.92% SMA50 -4.50% SMA200 -0.46% Trades
Volume 0 Change 0.00%
Aug-18-22 02:00PM
Dec-23-20 04:12PM
Nov-30-20 08:54AM
Jun-23-20 11:10AM
Feb-05-20 06:34AM
07:58AM
Loading…
Jan-13-20 07:58AM
Dec-23-19 12:00PM
Dec-19-19 07:05AM
Dec-02-19 02:40PM
Nov-27-19 06:52AM
Nov-25-19 06:55PM
Nov-14-19 01:31PM
Nov-05-19 08:32AM
Sep-20-19 11:04AM
Sep-06-19 03:07PM
03:18PM
Loading…
Sep-04-19 03:18PM
Aug-29-19 07:39AM
Aug-27-19 10:05AM
Aug-14-19 08:53AM
Aug-07-19 06:45AM
Aug-05-19 12:00PM
Jul-16-19 07:01AM
Jun-21-19 09:15AM
Jun-18-19 09:55AM
May-30-19 06:53AM
May-10-19 01:00PM
May-08-19 08:03AM
Apr-12-19 07:23AM
Apr-10-19 04:44PM
Mar-20-19 07:07AM
11:15AM
Loading…
Feb-26-19 11:15AM
Feb-25-19 01:59PM
Feb-20-19 09:32AM
Dec-13-18 07:32AM
Nov-21-18 09:47AM
Nov-20-18 02:03PM
Oct-30-18 08:08AM
Oct-08-18 08:25AM
Jul-31-18 03:52PM
Apr-12-18 07:19AM
Jan-10-18 04:10PM
Sep-21-17 02:13PM
11:56AM
Sep-12-17 09:06AM
Aug-23-17 04:18PM
Jul-10-17 02:35PM
Jun-14-17 03:04PM
Jun-09-17 04:47PM
May-05-17 05:16PM
Mar-13-17 05:46PM
05:46PM
Mar-02-17 02:00PM
Mar-01-17 09:06AM
Jan-27-17 04:30PM
Jan-12-17 10:08AM
Jan-09-17 07:36AM
Dec-15-16 01:04PM
Dec-02-16 10:04AM
Nov-08-16 03:26PM
Oct-27-16 12:19PM
Oct-11-16 08:04AM
Oct-07-16 01:16PM
Oct-05-16 09:42AM
Sep-01-16 11:04AM
Aug-31-16 03:39PM
Aug-24-16 10:04AM
Aug-23-16 09:30AM
Aug-04-16 09:47AM
Jul-27-16 11:57AM
Jul-25-16 09:20AM
Jul-23-16 12:00PM
Jul-12-16 05:05PM
Jul-11-16 10:05AM
Jul-05-16 10:53AM
Jun-29-16 05:09PM
10:59AM
Jun-10-16 09:06AM
May-13-16 04:48PM
May-11-16 06:05AM
May-04-16 09:00AM
Apr-07-16 04:04PM
Mar-18-16 08:20AM
Mar-09-16 06:37AM
Mar-01-16 11:27PM
Jan-22-16 09:31AM
Jan-21-16 06:18PM
(Investor's Business Daily)
Jan-13-16 12:09PM
Jan-11-16 01:38PM
Jan-08-16 02:10PM
Jan-05-16 07:49PM
(Investor's Business Daily)
Jan-04-16 08:38AM
Dec-24-15 04:48PM
09:59AM
Dec-21-15 12:22PM
Dec-08-15 08:20AM
Dec-03-15 10:29AM
08:02AM
Dec-01-15 10:07AM
Nov-30-15 01:38PM
Nov-23-15 08:24PM
(Investor's Business Daily)
Invesco Dynamic Biotechnology & Genome ETF seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
